Next Day Disclosure Returns - [Share Buyback]

Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.

Next Day Disclosure Return

Announcements and Notices - [Other - Business Update]

Voluntary Announcement - Research Updates On A Phase I/Ii Clinical Trial Of
Jskn033 For Presentation At Sitc 2024

Announcements and Notices - [Change in Company Secretary]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alphamab Co Ltd (9966 HK)

Next Day Disclosure Return

Voluntary Announcement - Research Updates On A Phase I/Ii Clinical Trial Of Jskn033 For Presentation At Sitc 2024

Next Day Disclosure Return

Next Day Disclosure Return

Waiver From Strict Compliance With Rules 3.28 And 8.17 Of The Listing Rules

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)